Moreover, experiments in vitro revealed that their levels, especially of SOX1 and SOX2, were significantly elevated in PR-LncRNA silencing cells and that knock-down of SOX1 and SOX9 expression dramatically reduced the pro-oncogenic activities promoted by PR-LncRNA silencing in glioma cells. This evidence concerns the gene SOX9 and glioma.